SCHOTT Pharma India Marks a New Chapter, Building on Its Strong India Presence and Global Capabilities
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓SCHOTT Poonawalla Private Limited will become SCHOTT Pharma India Private Limited effective 28 October 2026.
- ✓This change links the local business to the global brand.
- ✓CEO Roy Joseph said, "SCHOTT Pharma India represents the next chapter of our journey, combining our strength in India with SCHOTT Pharma's global innovation and expertise."
Story at a Glance
- Category
- MARKET
- Reported By
- The Hindu
- Reading Speed
- 4 Minute(s)
- Market Focus
- India Economy
New identity reinforces the company's focus on innovation, customer partnerships and pharmaceutical drug containment and delivery solutions
Mumbai, Maharashtra, India - Business Wire India
Effective 28 October 2026, SCHOTT Poonawalla Private Limited will become SCHOTT Pharma India Private Limited, marking an important new chapter in the company's journey and strengthening its connection with the global SCHOTT Pharma organization.
The new identity more clearly reflects the India business's place within SCHOTT Pharma's global network and its role in advancing high-quality drug containment and delivery solutions for the pharmaceutical and biotech industries. It brings together the company's strong manufacturing footprint, long-standing customer relationships and deep market expertise in India with SCHOTT Pharma's global capabilities, innovation and scientific excellence.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
The Hindu
Read the full, original unfiltered story directly on the publisher's portal.